BBIO Stock Analysis: Buy, Sell, or Hold?
BBIO - BridgeBio Pharma, Inc. Common Stock
$68.92
2.65 (4.00%)
▲
5d:
+3.17%
30d:
+1.03%
90d:
+0.55%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.5/10
Get Alerted When BBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BBIO shows positive signals but monitor for confirmation. Market pricing in 16.3% decline. Moderate conviction.
💡 BUY OPPORTUNITY: BBIO shows positive signals but monitor for confirmation. Market pricing in 16.3% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$18.47
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$11.47
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BBIO is currently trading at $68.92, which is considered extended relative to its 30-day fair value range of $65.78 to $68.63. From a valuation perspective, the stock is trading at a discount (Forward PE: 130.7) compared to its historical average (223.3). Remarkably, the market is currently pricing in an annual earnings decline of 16.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BBIO is in a strong uptrend. The price is approaching resistance at $69.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: BBIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $102.28 (+48.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BBIO is in a strong uptrend. The price is approaching resistance at $69.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: BBIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $102.28 (+48.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$65.78 -
$68.63
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.0%)
- BULLISH: Trading 48.4% below Wall St target ($102.28)
Trading Range Analysis
30-Day Trading Range
$65.78 -
$68.63
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$65.59
Resistance Level
$69.66
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
130.70
Wall Street Target
$102.28
(+48.4%)
Revenue Growth (YoY)
66.8%
Profit Margin
-124.4%
Valuation Discount vs History
-16.3% cheaper
PE vs Historical
130.7 vs 223.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.3%
(market-implied from PE analysis)
1-Year Target
$62.03
(-10%)
2-Year Target
$55.83
(-19%)
3-Year Target
$50.24
(-27%)
3-Yr Target (if PE normalizes)
(PE: 131→223)
$85.84
(+25%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 130.7 to 223.3
Stabilization Target:
$117.75
(+70.8%)
PE Expansion Potential:
+70.8%
Share & Embed Analysis
Last updated: June 23, 2026 9:01 AM ET
Data refreshes hourly during market hours. Next update: 10:01 AM
Data refreshes hourly during market hours. Next update: 10:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBIO showing a specific setup today?
Insider Activity (6 Months)
3
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Neil Kumar
SELL
40000 shares
2026-04-09
Gilbert Ray Cisneros, Jr.
BUY
2026-03-19
Gilbert Ray Cisneros, Jr.
BUY
2026-03-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 56 HOLD |
Advanced BBIO Option Strategies
Professional options setups generated by AI based on today's BBIO price and gamma walls.
